Navigation Links
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Date:9/3/2008

MADISON, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced the appointment of Daniel J. McIntyre, 54, to Vice President, Corporate Communications. Reporting to Timothy P. Cost, Senior Vice President, Corporate Affairs, Mr. McIntyre will be responsible for all internal and external communications for the corporation and its three major divisions -- pharmaceuticals, consumer health care and animal health -- around the world.

Prior to joining Wyeth, Mr. McIntyre held a series of senior executive positions in communications and health care. Most recently, he was Managing Director of the healthcare practice of Fleishman-Hillard International Communications. He previously served in senior level Communications and Public Policy positions for Pharmacia Corporation, Bayer Corporation's Pharmaceutical Division, the Bristol-Myers Squibb Company, and Hoffmann-La Roche Inc.

"Wyeth is in one of the most important periods in its history," says Mr. Cost. "We are building momentum toward developing new therapies for patients even as we transform our organization for the future. Having Dan now leading our communications team is an important part of our plan to meet new and evolving challenges."

An honors graduate of Seton Hall University, McIntyre holds an MPA from Rutgers University. He is a member of the executive committee of the Rutgers University Foundation, and has served on the boards of trustees of Caldwell College, the American Association for World Health, the New England Healthcare Institute (NEHI) and Connecticut United for Research Excellence (CURE). He is also a member of the Public Relations Society of America (PRSA).

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
2. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
3. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
4. Wyeth Declares Common and Preferred Stock Dividends
5. Wyeth Pharmaceuticals Announces Organizational Change
6. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
7. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
8. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
9. Wyeth Chairman Robert Essner Announces June 27 Retirement
10. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
11. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... Hill, N.C. (PRWEB) , ... June 27, 2016 ... ... U.S. commercial operations for Amgen, will join the faculty of the University ... serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
Breaking Biology Technology:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):